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Symptomatic and asymptomatic Coxiella burnetii infection during pregnancy have been associated with
obstetric complications. We described placental histopathology and clinical outcome of ﬁve cases with
asymptomatic C. burnetii infection during pregnancy and compared these cases with four symptomatic
cases from the literature. In contrast with the symptomatic cases, we did not observe necrosis or active
inﬂammation in the placentas of the asymptomatic women. Obstetrical outcome was more favourable in
the asymptomatic cases than in the symptomatic cases. Asymptomatic and symptomatic C. burnetii
infection during pregnancy are different entities with respect to placental histopathology and the risk of
obstetric complications.
 2011 Elsevier Ltd. Open access under the Elsevier OA license.1. Introduction
Several European countries notiﬁed increasing numbers of
human Q fever since 2007 [1,2]. Q fever is a zoonosis caused by the
intracellular bacterium Coxiella burnetii. It primarily infects rumi-
nants and rodents, in which the infection is mainly associated with
miscarriage and stillbirth [3]. Humans are predominantly infected
by inhalation of contaminated aerosols [4].
Up to 90% of pregnant womenwith antibodies suggesting recent
infection with C. burnetii remain asymptomatic [5]. However,
symptomatic and asymptomatic C. burnetii infection during preg-
nancy have been associated with obstetric complications, including
miscarriage, preterm delivery and fetal death [6,7]. Placental
infection assessed by polymerase chain reaction (PCR) or culture
has been strongly related to these complications [6]. However,
information about placental histopathology, in particular in
asymptomatic cases, is lacking. Therefore, we described placental
histopathology from women with asymptomatic C. burnetiirescence assay; Ig, immuno-
n reaction; PPROM, preterm
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with symptomatic cases described in the literature.
2. Patients and methods
2.1. Setting and participants
This study was embedded in a clustered randomised controlled trial about the
effectiveness of a screening program for C. burnetii infection during pregnancy. In
that study pregnant women living in Q fever high-risk areas in The Netherlands
were serologically screened for C. burnetii infection. Details about the screening
study are described elsewhere [8]. The study protocol was approved by the Medical
Ethical Review Board of the University Medical Centre Groningen (UMCG). All
participants included in this study gave written informed consent to collect and
analyse placental tissue and clinical outcome data.
2.2. Design
From women who participated in the intervention group of the screening trial
and who had serological evidence for an acute infection, placentas were collected.
An acute infection was deﬁned as the presence (cut-off titre  1:32) of immuno-
globulin (Ig)M accompanied with (rising) IgG during follow-up. Serology was per-
formed with indirect immunoﬂuorescence assay (IFA, Focus Diagnostics, Cypress,
CA, USA). Placentas were histopathologically analysed by one pathologist (AT) from
the UMCG. Furthermore, C. burnetii speciﬁc real-time PCR was performed. Primers
and probes used have been described earlier [9], other technical details are available
on request.
2.3. Systematic review
A systematic review of the literature was done by searching PubMed and the
references of the included papers following the PRISMA-guidelines. Our search was
limited to human studies in English or Dutch. The search strategy was: ‘’Q fever OR
Table 1
Summary of patient characteristics and placental histopathology.
Age (y) Parity Symptoms Initial serological valuesa Treatment Gestational
age at delivery
(wks þ days)
Birth weight
(g/percentile)
Clinical outcome C. burnetii
present in
placenta tissue?
Placental weight
(g/percentile)
Summery of
placenta histology
IgM II IgM I IgG II IgG I
Asymptomatic
patients
1 31 0 None 1:1024 1:32 1:512 <1:32 Erythromycin 42 þ 0 4030/50e80th Arrest of
second stage
of labour;
uncomplicated
caesarean
section at term
PCR negative Unknown No signiﬁcant
pathology
2 32 0 None 1:256 1:32 1:1024 1:128 Erythromycin 37 þ 0 2930/50e80th Suspicion
of solution
placentae at
term; emergency
caesarean section
PCR negative 540/75e90th No signiﬁcant
pathology
3 31 0 None 1:512 1:64 1:256 <1:32 Erythromycin 34 þ 1 2170/50e80th PPROM, retained
placenta, postpartum
haemorrhage
PCR negative 337/10e25th Maternal vascular
underperfusion;
ﬁbromuscular
hyperplasia of
stemvillus vessels;
scattered ﬁbrotic
villi, low grade
chronic villitis
(Fig. 1)
4 34 0 None 1:512 <1:32 1:128 <1:32 None 39 þ 6 3535/50e80th Uncomplicated,
at term
PCR negative 425/<10th Placental
hypoplasia
5 33 1 None 1:256 <1:32 1:128 <1:32 None 40 þ 2 3535/20e50th Congenital
hydronephrosis,
meconium stained
amniotic ﬂuid at term
NA 528/25e50th Low grade chronic
villitis
Symptomatic
cases from
the literature
1 Reich-man
et al., 1988
29 2 Fever,
headache,
weakness,
sweating,
purpuric
rash
1:400 1:1600 1:1600 1:400 Tetracycline 28 1000/unknown Induced labour
because of maternal
illness
Immunoﬂuorescent
stain positive
Unknown Areas of necrosis
2 Raoult
et al., 1994
26 Unknown Fever,
cough
Unknown; seroconversion Cotrimoxazole 24 Unknown Miscarriage Immunoﬂuorescent
stain positive
Unknown Multiple foci
of necrosis
3 Friedland
et al., 1994
26 Unknown Fever,
fatigue,
dyspnoea
Unknown; rising antibodies Erythromycin
postpartum
25 Unknown Oligohydramnios,
intrauterine
fetal death
Immunocytochemical
strain positive
Unknown Severe necrotising
villitis in 40% of
the placental tissue
4 Bental
et al., 1995
28 Unknown Fever,
cough,
arthralgia
1:1600 1:200 1:800 1:25000 Erythromycin/
rifampicin
30 1300/unknown Premature labour,
caesarean section
because of transverse
lie of the fetus
PCR positive Unknown No areas of
necrosis or other
gross pathology
y, years Ig, immunoglobulin wks, weeks g, grams PCR, polymerase chain reaction NA, not applicable due to PCR inhibition PPROM, preterm premature rupture of membranes.
a Serology of the asymptomatic cases was performed with indirect immunoﬂuorescence assay (IFA, Focus Diagnostics, Cypress, CA, USA), measuring both IgM and IgG against phase I and II antigens. Serology of the symptomatic cases was
performed with in-house assays.
Fig. 1. Hematoxylin and eosin stain of placental tissue from asymptomatic case no 3,
demonstrating ﬁbrotic chorionvilli, loss of capillaries, stromal karyorrhexi and hae-
morrhage (magniﬁcation 10).
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afterwards the eligibility of the studies was judged by reading the full-texts. Only
studies describing human placental histopathology were included.3. Results
Seven of the 536 women in the intervention group of the
screening trial had serological proﬁles suggesting an acute
C. burnetii infection and were treated with antibiotics. Overall, ﬁve
placentas were stored and send for re-evaluation to the UMCG,
including two placentas from women with follow-up serology
suggesting a previous infection. All cases were asymptomatic at the
moment of screening. Clinical outcome and placental histopa-
thology are summarised in the ﬁrst part of Table 1.
The PubMed search resulted in 30 hits. Only 2 papers included
data on human placental histopathology and were included. Two
other reports were included based on the references. All included
papers concerned case-reports of symptomatic acute or chronic Q
fever cases [10e13]. Clinical outcome and placental histopathology
of these cases are summarised in the second part of Table 1.4. Discussion
We showed that asymptomatic and symptomatic C. burnetii
infection during pregnancy are different entities with respect to
placental pathology and the risk of obstetric complications.
Placental histology in the asymptomatic cases showed, in contrast
with the symptomatic cases, no foci of necrosis or active inﬂam-
mation. We only observed a few scattered ﬁbrotic villi, which could
be a result of interruption of fetal blood ﬂow or destruction of
capillaries due to previous villitis [14]. The presence of low grade
chronic villitis is a frequent ﬁnding in third trimester placentas and
probably related to a maternal immune response directed against
fetal antigens inherited from the father. Until present no microbi-
ological pathogens have been linked to chronic villitis [15].
Whether placenta hypoplasia and pathology consistent with
maternal vascular underperfusion are linked to C. burnetii infection
is to our knowledge unknown.
In none of the placentas from asymptomatic cases C. burnetii
could be detected with PCR. Previously this also has been shown for
a larger cohort of 153 asymptomatic seropositive women [7],suggesting that the rate of placental infection during asymptomatic
C. burnetii infection is very low.
Our ﬁndings are in line with animal studies. In cows, where Q
fever is usually not clinically apparent, positive PCR on bulk tank
milk is only rarely associated with histopathological inﬂammation
of placentas [16]. On the other hand, in goats and sheep, in which
C. burnetii infection is often associated with miscarriage and still-
birth, necrotising inﬂammation of placental tissue is a common
ﬁnding [17,18].
Various factors, including host immune response, cytokines and
different strains of C. burnetii, have been suggested to play a role in
the clinical manifestation and outcome of C. burnetii infection in
both animals and humans, but further research is needed to ﬁnd
target points for prevention and treatment [18e20].
In conclusion, after asymptomatic C. burnetii infection during
pregnancy placental examination reveals no major pathology
related to previous villitis, which is associated with a favourable
clinical outcome. Symptomatic infection is a different entity.
Obstetric complications in these cases can verywell be explained by
colonisation with C. burnetii and massive necrosis of the placenta.Authors’ contributions
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